Universite de Lausanne
Records under this name other than the patents Universite de Lausanne holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Universite de Lausanne
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,815,310 | Multispecific Antigen Binding Fragments and Multispecific Antibodies Derived Therefrom Comprising Mutant CH1 and Cl-Kappa Domains No holder on record In force · Medium confidence | In force | Medium confidence | |
| US 12,378,325 | Multispecific Antigens Binding Fragments and Multspecific Antibodies No holder on record In force · Medium confidence | In force | Medium confidence | |
| US 9,631,031 | Multispecific Antigens Binding Fragments and Multispecific Antibodies Derived Therefrom Comprising Mutant CH1 and Cl-Kappa Domains Formerly held In force · High confidence | In force | High confidence | |
| US 11,319,590 | Enhanced Immune Cell Receptor Sequencing Methods Formerly held In force · High confidence | In force | High confidence | |
| US 12,297,276 | ANTI-TEM1 Antibodies and Antigen-Binding Portions Thereof Held by another company In force · High confidence | In force | High confidence | |
| US 8,741,297 | Preparation of isolated agonist anti-EDAR monoclonal antibodies Formerly held Lapsed on the fee record Ended Jun 3, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 3, 2026 | USPTO record |
| US 8,236,924 | Cell-permeable peptide inhibitors of the JNK signal transduction pathway Formerly held Term ended Term ended Feb 27, 2026 · USPTO record | Term ended | Term ended Feb 27, 2026 | USPTO record |
| US 8,644,905 | Magnetic Resonance Imaging Formerly held Lapsed on the fee record Ended Feb 4, 2026 · High confidence | Lapsed on the fee record | Ended Feb 4, 2026 | High confidence |
| US 8,496,937 | Preparation of isolated agonist anti-EDAR monoclonal antibodies Formerly held Lapsed on the fee record Ended Jul 30, 2025 · USPTO record | Lapsed on the fee record | Ended Jul 30, 2025 | USPTO record |
| US 7,580,737 | Method and apparatus for determining treatment for stroke Term ended Term ended Jan 29, 2025 · USPTO record | Term ended | Term ended Jan 29, 2025 | USPTO record |